key: cord-0685016-0tsucdud authors: Kuerer, Henry M.; Blair, Sarah L. title: The Virtual Scientific Sessions from the American Society of Breast Surgeons During the COVID-19 Pandemic date: 2020-08-18 journal: Ann Surg Oncol DOI: 10.1245/s10434-020-08946-0 sha: cc748d10de224fb14c6f01f0c1f87190f93b80c6 doc_id: 685016 cord_uid: 0tsucdud nan Suddenly, the world entirely changed and everything we knew and were used to also had to change, including inperson national meetings. The pandemic did not allow for a safe 21st Annual Meeting of the American Society of Breast Surgeons to take place, scheduled for Las Vegas, Nevada. The one thing that did not change was the member drive for knowledge to advance breast care and decrease the burden of breast cancer for our patients all around the world. Another thing that did not change was the executive physician and staff leadership that rapidly turned our scientific sessions as oral presentations into the new normal of virtual meetings and allowed for presentation of the posters on our website. This historic year for our world and our society renewed our commitment to helping attendees elevate standard practice by improving the efficacy, safety, and quality of breast care for our patients and sharing the best of these advancements in this year's breast issue of the Annals of Surgical Oncology. Much gratitude is given to the 33 members of the Publication Committee for careful review of 372 research abstracts for selection of the top studies for oral scientific, 'quick-shot', and poster presentations, and final review and selection of the highest impact publications for this issue of Annals of Surgical Oncology. Just some of the highlighted research studies published in this issue of Annals of Surgical Oncology include pivotal and essential work regarding enhanced patient recovery and decreasing the use of opioid prescriptions for pain management after breast cancer surgery, 1-4 understanding and further integration of neoadjuvant systemic (including hormonal) therapies to facilitate improved patient outcomes, [5] [6] [7] [8] [9] and further elucidation and updates on breast reconstruction and standardizing oncoplastic surgery. [10] [11] [12] [13] [14] The annual Outstanding Scientific Presentation Award for the best abstract presented by a resident, medical trainee, or fellow went to Dr. Daniel Lustig for his important work on development of a risk calculator to predict a low risk for malignancy upgrade when atypical ductal hyperplasia is diagnosed by image-guided biopsy, in order to identify patients most likely to benefit from surgical excisons. 15 The George Peter's Award for the best presentation by a fellow went to Dr. Britany Murphy for her work on emerging multi-gene panel testing and performance of contralateral prophylactic masectomy. 16 These and other ASBrS articles published in this issue [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] provide current research results germane to today's delivery of high-quality breast cancer care. The pandemic is currently still active and the future ramifications of delayed and canceled screening, surgeries, and marked increases in neoadjuvant systemic therapy use for breast cancer will be evaluated in research studies for years to come. The impact on these dramatic changes in breast and other malignancies with respect to recurrence, survival, and emotional well-being will also be the subject of future research presentations at this society and others. In the final analysis, it is anticipated that there will be lessons learned and these practices will be incorporated into continuing enhanced standards in breast cancer care and global healthcare in general. DISCLOSURES The authors declare no conflict of interest. First Received: 13 July 2020 Accepted: 13 July 2020 Changing the default: a prospective study of reducing discharge opioid prescription after lumpectomy and sentinel node biopsy Obese patients who receive an opioid-sparing enhanced recovery after surgery (ERAS) protocol are at increased risk of persistent pain after breast surgery Post-operative nausea and analgesia following total mastectomy is improved after implementation of an enhanced recovery protocol Pain management in breast surgery: recommendations of a multi-disciplinary expert panel from the American Society of Breast Surgeons Performance and clinical utility of models predicting eradication of nodal disease in patients with clinically node positive breast cancer treated with neoadjuvant chemotherapy by tumor biology How effective is neoadjuvant endocrine therapy (NET) in downstaging the axilla and achieving breast conserving surgery (BCS)? Ann Surg Oncol Does use of neoadjuvant chemotherapy affect the decision to pursue fertility preservation options in young women with breast cancer? Oncologic outcomes of sentinel lymph node surgery after neoadjuvant chemotherapy for node positive breast cancer Node-positive patients treated with neoadjuvant chemotherapy can be spared axillary lymph node dissection with wireless non-radioactive localizers Breast reconstruction in the setting of stage IV breast cancer: is it worthwhile? Early free range of motion upper limb exercises after mastectomy and immediate implant reconstruction are safe and beneficial: a randomized trial Do nipple necrosis rates differ in pre-pectoral versus sub-muscular implantbased reconstruction after nipple sparing mastectomy? National trends in immediate breast reconstruction: an analysis of implant-based versus autologous reconstruction after mastectomy Development and prospective validation of a risk calculator that predicts a low risk cohort for atypical ductal hyperplasia upstaging to malignancy: evidence for a watch and wait strategy of a high-risk lesion Contralateral risk-reducing mastectomy in breast cancer patients who undergo multigene panel testing Factors associated with pathological node negativity in inflammatory breast cancer: are there patients who may be candidates for a de-escalation of axillary surgery? The diminishing impact of margin definitions and width on local recurrence rates following breast-conserving therapy for early-stage invasive cancer: a metaanalysis Impact of phone-call and access-enhancing intervention on mammography uptake among primary care patients at an urban safety-net hospital: a randomized-controlled study Cosmetic outcomes following breast-conservation surgery and radiation for multiple ipsilateral breast cancer: data from the Alliance Z11102 Study Has breast surgery shattered the glass ceiling? Axillary response in patients undergoing neoadjuvant endocrine treatment for node positive breast cancer-systematic literature review and NCDB analysis Single hormone receptor-positive breast cancers have distinct characteristics and survival Lymphedema prevention surgery: improved operating efficiency over time Population trends in lobular carcinoma of the breast: the Ontario experience Surgery for men with breast cancer: do the same data still apply? Differences in re-excision rates for breast-conserving surgery using intraoperative 2D versus 3D tomosynthesis specimen radiograph Ipsilateral and concurrent breast cancer and atypical ductal hyperplasia: does atypia also need surgical excision? Clinico-pathological evaluation of the potential anatomic pathways of systemic metastasis from primary breast cancer suggests an orderly spread through the regional lymph nodes Adoption of opioidsparing and non-opioid regimens after breast surgery in a large, integrated health care delivery system Clinical factors affecting the therapeutic efficacy of evening primrose oil on mastalgia Survival outcomes of earlystage hormone receptor positive breast cancer in elderly women Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations Comprehensive Virtual Breast Cancer Scientific Sessions